Concepedia

Michèle Tameris

MT

Statistics

Publications

79

Citations

7.3K

H-Index

41

Active since

2006

Affiliations

South African Tuberculosis Vaccine Initiative(Current)

University of Cape Town

Aeras

Stellenbosch University

South African Medical Research Council

Michèle Tameris is an author at South African Tuberculosis Vaccine Initiative specializing in infectious diseases, vaccinology, and immunology.

ORCID

Publications per year

2006–2025

79

Publications

79

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Michèle Tameris, Mark Hatherill, Bernard Landry et al. · The Lancet · 2013 · 1K citations · Full text

, , +14

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Vivek Shinde, Sutika Bhikha, Zaheer Hoosain et al. · New England Journal of Medicine · 2021 · 662 citations · Full text

, , +17

Final Analysis of a Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

Dereck Tait, Mark Hatherill, Olivier Van Der Meeren et al. · New England Journal of Medicine · 2019 · 595 citations · Full text

, , +17

Phase 2b Controlled Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba et al. · New England Journal of Medicine · 2018 · 412 citations · Full text

, , +17

T-cell activation is an immune correlate of risk in BCG vaccinated infants

Helen A. Fletcher, Margaret Ann Snowden, Bernard Landry et al. · Nature Communications · 2016 · 272 citations · Full text

, , +17

1–5 of 79